Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers - Concepedia

Concepedia

Publication | Closed Access

Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: A single- and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation study in healthy Korean male volunteers

68

Citations

16

References

2010

Year

Jinah Jung, Sang-Min Choi, Sang‐Heon Cho, Jong‐Lyul Ghim, Ae-Kyung Hwang, Unjib Kim, Bong Sik Kim, Atsushi Koguchi, Shinji Miyoshi, Hirotaka Okabe,

Clinical Therapeutics

Dose-escalation StudyPhosphodiesterase Type 5PharmacologyAntiviral TherapyClinical PharmacologyPharmacotherapyMedicine

References

	Year	Citations

Page 1